Comments
Loading...
LAVA Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:LVTX | Benzinga
LAVA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-0.270
Quarterly Revenue Estimate
$2.40M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$7.34M
Analyze the earnings history of LAVA Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics | -$0.02 | -$0.34 | — | — | $6.99M | — | — | — | 05/20/2025 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.24 | -$0.27 | — | — | $353.00K | $2.40M | — | — | 04/08/2025 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.34 | -$0.33 | -$0.46 | -39.39% | $53.00K | — | $0.00 | — | 12/10/2024 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.48 | -$0.36 | -$0.31 | 13.89% | $5.14M | — | $0.00 | — | 08/20/2024 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.53 | -$0.12 | -$0.02 | 83.33% | $1.22M | $7.00M | $6.99M | -0.11% | 05/21/2024 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.57 | -$0.12 | -$0.24 | -100.00% | $2.64M | $6.25M | $353.00K | -94.35% | 03/20/2024 | Get Alert |
| LVTX | LAVA Therapeutics | $0.04 | — | -$0.34 | — | $15.26M | — | $53.00K | — | 11/16/2023 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.31 | -$0.47 | -$0.48 | — | $468.00K | $830.00K | $5.14M | 519.16% | 08/22/2023 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.41 | -$0.52 | -$0.53 | -1.92% | $1.00M | — | $1.22M | — | 06/08/2023 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.32 | -$0.64 | -$0.57 | 10.94% | $1.00M | $250.00K | $2.64M | 956.00% | 04/11/2023 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.27 | -$0.15 | $0.04 | 126.67% | $2.10M | $10.53M | $15.26M | 44.93% | 11/16/2022 | Get Alert |
| LVTX | LAVA Therapeutics | -$0.31 | -$0.60 | -$0.31 | 48.33% | $1.08M | $340.00K | $468.00K | 37.65% | 09/13/2022 | Get Alert |
| LVTX | LAVA Therapeutics | -$12.29 | -$0.86 | -$0.41 | 52.33% | $1.11M | — | $1.00M | — | 05/17/2022 | Get Alert |
| LVTX | LAVA Therapeutics | -$12.97 | -$0.40 | -$0.32 | 20.00% | $2.00M | — | $1.00M | — | 03/24/2022 | Get Alert |
| LVTX | LAVA Therapeutics | -$8.43 | -$0.31 | -$0.27 | 12.90% | $827.00K | — | $2.10M | — | 11/15/2021 | Get Alert |
| LVTX | LAVA Therapeutics | — | -$0.27 | -$0.28 | -3.70% | — | — | $1.08M | — | 08/16/2021 | Get Alert |
| LVTX | LAVA Therapeutics | — | — | -$12.29 | — | — | — | $1.11M | — | 05/20/2021 | Get Alert |
LAVA Therapeutics (LVTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-12-10 | $-0.46 | $-0.33 | -39.4 % |
| Q2 | 2024-08-20 | $-0.31 | $-0.36 | 13.9 % |
| Q1 | 2024-05-21 | $-0.02 | $-0.12 | 83.3 % |
| Q4 | 2024-03-20 | $-0.24 | $-0.12 | -100.0 % |
LAVA Therapeutics (LVTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-21 | $6.99M | $7.00M | -0.11 % |
| Q4 | 2024-03-20 | $353.00K | $6.25M | -94.3 % |
| Q2 | 2023-08-22 | $5.14M | $830.00K | 519.2 % |
| Q4 | 2023-04-11 | $2.64M | $250.00K | 956.0 % |
FAQ
When is LAVA Therapeutics (NASDAQ:LVTX) reporting earnings?
LAVA Therapeutics (LVTX) is scheduled to report earnings on May 20, 2025. The last reported earnings were for reported on December 10, 2024 for Q3.
What were the latest earnings per share (EPS) for LAVA Therapeutics (NASDAQ:LVTX)?
The Actual EPS was $-0.46, which missed the estimate of $-0.33.
What were LAVA Therapeutics’s (NASDAQ:LVTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.